CDRT8

Across TCGA pan-cancer cohorts, CDRT8 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated CDRT8 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher CDRT8 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CDRT8 expression acts as an unfavorable survival marker, although some lineages such as UCS and PAAD show a favorable association.

KIRP, UVM, and SKCM are the cancer types where CDRT8 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	II,III,IV	0.111	0.828	<.001	81	view →
UVM	OS	Tertile	II,III,IV	0.218	0.718	.006	72	view →
SKCM	DFS	Tertile	IV	0.042	0.477	.001	63	view →
STAD	DFS	Tertile	All	0.414	0.735	.001	54	view →
BRCA	DFS	Tertile	All	0.140	1.000	.001	48	view →
UCS	DFS	Tertile	II,III,IV	0.707	0.296	.003	48	view →
KIRC	DFS	Tertile	All	0.246	0.650	.001	27	view →
LGG	OS	Tertile	All	0.218	0.468	<.001	24	view →
BLCA	OS	Tertile	IV	0.119	0.593	.001	21	view →
THCA	DFS	Tertile	II,III,IV	0.136	0.764	.008	18	view →
LUAD	OS	Tertile	III,IV	0.314	0.665	.031	18	view →
TGCT	DFS	Tertile	II,III,IV	0.088	0.917	.010	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

CDRT8–KIRP (OS)

Open the KIRP breakdown →